Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNP CenterPoint Energy	$37.36 +1.2%	$34.18	$25.41 ▼ $37.70	$24.39B	0.65	5.40 million shs	5.21 million shs
ETR Entergy	$84.89 -2.0%	$83.59	$50.19 ▼ $88.38	$36.57B	0.56	3.62 million shs	6.50 million shs
EXC Exelon	$47.23 +2.7%	$43.05	$34.01 ▼ $47.60	$47.68B	0.51	6.89 million shs	12.66 million shs
PFE Pfizer	$24.30 -1.6%	$25.93	$24.28 ▼ $31.54	$137.79B	0.61	39.31 million shs	53.41 million shs
SGEN Seagen	$228.74	$228.74	$123.77 ▼ $228.96	$42.93B	0.32	1.48 million shs	86 shs
ZBH Zimmer Biomet	$112.72 +0.2%	$107.38	$97.69 ▼ $130.89	$22.44B	1.04	1.58 million shs	2.92 million shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNP CenterPoint Energy	+0.42%	+4.01%	+6.91%	+17.37%	+29.96%
ETR Entergy	+1.21%	+3.12%	-1.47%	+14.95%	+64.68%
EXC Exelon	+0.11%	+4.43%	+3.19%	+22.07%	+22.33%
PFE Pfizer	+0.84%	-1.84%	-5.65%	-7.07%	-10.24%
SGEN Seagen	0.00%	0.00%	0.00%	0.00%	0.00%
ZBH Zimmer Biomet	+0.19%	+1.76%	+6.92%	+7.74%	-12.40%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNP CenterPoint Energy	3.2247 of 5 stars	2.2	2.0	2.5	1.4	3.4	1.7	0.6
ETR Entergy	3.7505 of 5 stars	2.4	3.0	1.7	2.4	3.0	1.7	1.3
EXC Exelon	4.2438 of 5 stars	2.3	3.0	3.3	3.3	2.9	2.5	1.3
PFE Pfizer	4.971 of 5 stars	3.3	3.0	4.2	4.2	3.3	3.3	3.1
SGEN Seagen	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	4.6856 of 5 stars	3.2	5.0	1.7	3.7	3.6	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNP CenterPoint Energy	2.31	Hold	$34.46	-7.76% Downside
ETR Entergy	2.73	Moderate Buy	$84.75	-0.16% Downside
EXC Exelon	2.56	Moderate Buy	$45.13	-4.46% Downside
PFE Pfizer	2.63	Moderate Buy	$31.92	31.40% Upside
SGEN Seagen	0.00	N/A	N/A	N/A
ZBH Zimmer Biomet	2.32	Hold	$124.15	10.15% Upside

Current Analyst Ratings Breakdown

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/2/2025	CNP CenterPoint Energy	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$42.00
3/27/2025	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
3/21/2025	ETR Entergy	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$86.00 ➝ $96.00
3/21/2025	EXC Exelon	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$45.00 ➝ $47.00
3/20/2025	CNP CenterPoint Energy	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$32.00 ➝ $34.00
3/20/2025	ETR Entergy	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$75.00 ➝ $78.00
3/20/2025	EXC Exelon	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$46.00 ➝ $48.00
3/18/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/17/2025	CNP CenterPoint Energy	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$35.00 ➝ $36.00
3/12/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/11/2025	CNP CenterPoint Energy	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$34.00 ➝ $36.00

(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNP CenterPoint Energy	$8.64B	2.82	$4.22 per share	8.86	$16.37 per share	2.28
ETR Entergy	$11.88B	3.08	$9.29 per share	9.14	$35.04 per share	2.42
EXC Exelon	$23.03B	2.07	$6.64 per share	7.11	$26.78 per share	1.76
PFE Pfizer	$63.63B	2.17	$3.81 per share	6.38	$15.81 per share	1.54
SGEN Seagen	$2.30B	18.66	N/A	N/A	$15.10 per share	15.15
ZBH Zimmer Biomet	$7.68B	2.92	$14.36 per share	7.85	$62.67 per share	1.80

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNP CenterPoint Energy	$917M	$1.59	23.50	19.98	2.71	11.79%	10.02%	2.48%	4/29/2025 (Estimated)
ETR Entergy	$2.36B	$2.43	34.86	19.74	2.34	8.90%	10.68%	2.49%	4/23/2025 (Estimated)
EXC Exelon	$2.46B	$2.45	19.28	16.99	2.86	10.68%	9.52%	2.38%	5/1/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	17.23	8.02	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)
SGEN Seagen	-$610.31M	-$4.01	N/A	N/A	N/A	-32.61%	-28.06%	-20.92%	N/A
ZBH Zimmer Biomet	$903.70M	$4.45	25.33	12.71	1.95	11.77%	12.99%	7.58%	5/1/2025 (Estimated)

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	N/A	EXC Exelon	$0.71	N/A	N/A	N/A	$6.30 billion	N/A
5/1/2025	N/A	ZBH Zimmer Biomet	$1.77	N/A	N/A	N/A	$1.89 billion	N/A
4/29/2025	N/A	CNP CenterPoint Energy	$0.58	N/A	N/A	N/A	$2.73 billion	N/A
4/29/2025	N/A	PFE Pfizer	$0.67	N/A	N/A	N/A	$14.43 billion	N/A
4/23/2025	N/A	ETR Entergy	$0.60	N/A	N/A	N/A	$3.13 billion	N/A
2/20/2025	Q4 2024	CNP CenterPoint Energy	$0.40	$0.40	N/A	$0.38	$2.46 billion	$2.26 billion
2/18/2025	Q4 24	ETR Entergy	$0.63	$0.66	+$0.03	$0.65	$3.24 billion	$2.74 billion
2/12/2025	Q4 2024	EXC Exelon	$0.59	$0.64	+$0.05	$0.64	$5.44 billion	N/A
2/6/2025	Q4 24	ZBH Zimmer Biomet	$2.30	$2.31	+$0.01	$1.20	$2.01 billion	N/A
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNP CenterPoint Energy	$0.88	2.36%	+7.61%	55.35%	N/A
ETR Entergy	$2.40	2.83%	+5.94%	98.77%	N/A
EXC Exelon	$1.60	3.39%	-0.22%	65.31%	N/A
PFE Pfizer	$1.72	7.08%	+2.50%	121.99%	16 Years
SGEN Seagen	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	0.85%	N/A	21.57%	N/A

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/26/2025	ZBH Zimmer Biomet	quarterly	$0.24	0.89%	3/31/2025	3/31/2025	4/30/2025
2/12/2025	EXC Exelon	quarterly	$0.40	3.7%	2/24/2025	2/24/2025	3/14/2025
1/31/2025	ETR Entergy	quarterly	$0.60	2.96%	2/10/2025	2/10/2025	3/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNP CenterPoint Energy	1.91	1.08	0.92
ETR Entergy	1.81	0.72	0.59
EXC Exelon	1.61	0.87	0.78
PFE Pfizer	0.63	1.00	0.73
SGEN Seagen	N/A	2.67	2.12
ZBH Zimmer Biomet	0.43	1.91	0.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNP CenterPoint Energy	91.77%
ETR Entergy	88.07%
EXC Exelon	80.92%
PFE Pfizer	68.36%
SGEN Seagen	84.26%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
CNP CenterPoint Energy	0.14%
ETR Entergy	0.39%
EXC Exelon	0.10%
PFE Pfizer	0.06%
SGEN Seagen	25.90%
ZBH Zimmer Biomet	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNP CenterPoint Energy	12,500	652.73 million	650.55 million	Optionable
ETR Entergy	11,700	430.77 million	428.73 million	Optionable
EXC Exelon	19,100	1.01 billion	1.00 billion	Optionable
PFE Pfizer	83,000	5.67 billion	5.66 billion	Optionable
SGEN Seagen	3,256	187.70 million	139.08 million	Optionable
ZBH Zimmer Biomet	18,000	199.06 million	197.18 million	Optionable

EXC, ETR, CNP, PFE, ZBH, and SGEN Headlines

Recent News About These Companies

Diametric Capital LP Takes Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

April 3 at 5:46 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Holdings Decreased by Arrowstreet Capital Limited Partnership

April 3 at 4:38 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by Pictet Asset Management Holding SA

April 3 at 4:18 AM | marketbeat.com

Zimmer Biomet RibFix Advantage Fixation System receives CE Mark certificationr

April 2 at 12:37 PM | pharmabiz.com

Zimmer Biomet receives CE Mark approval for RibFix Advantage Fixation System

April 2 at 7:36 AM | markets.businessinsider.com

Zimmer Biomet wins CE mark for rib fixation system

April 2 at 7:36 AM | massdevice.com

Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System

April 2 at 7:36 AM | msn.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Franklin Resources Inc.

April 2 at 5:50 AM | marketbeat.com

Allstate Corp Makes New $669,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

April 2 at 4:48 AM | marketbeat.com

Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System

April 1 at 7:30 AM | prnewswire.com

Norges Bank Acquires New Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

April 1 at 4:24 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Korea Investment CORP

April 1 at 4:05 AM | marketbeat.com

1 S&P 500 Stock with Exciting Potential and 2 to Brush Off

March 31 at 10:25 PM | finance.yahoo.com

Zimmer Biomet Holdings (NYSE:ZBH) Might Have The Makings Of A Multi-Bagger

March 31 at 5:24 PM | finance.yahoo.com

Bcwm LLC Purchases New Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 31 at 6:58 AM | marketbeat.com

29,404 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Allianz SE

March 31 at 5:28 AM | marketbeat.com

NEOS Investment Management LLC Buys 2,485 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 31 at 4:36 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by UniSuper Management Pty Ltd

March 31 at 4:29 AM | marketbeat.com

Elo Mutual Pension Insurance Co Purchases 3,746 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 31 at 4:27 AM | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Buys 11,777 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 31 at 4:20 AM | marketbeat.com

Corebridge Financial Inc. Lowers Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 31 at 4:03 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
By Thomas Hughes | March 6, 2025
View Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
3 Stocks Near 52-Week Lows With Strong Rebound Potential
By Gabriel Osorio-Mazilli | March 31, 2025
View 3 Stocks Near 52-Week Lows With Strong Rebound Potential
3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
By Sarah Horvath | March 17, 2025
View 3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
Institutional Investors Bet $1B on These 4 Stocks—Should You?
By Sarah Horvath | March 9, 2025
View Institutional Investors Bet $1B on These 4 Stocks—Should You?
Best of Both Worlds: 3 ETFs With High Dividend Yields, Low Fees
By Nathan Reiff | March 26, 2025
View Best of Both Worlds: 3 ETFs With High Dividend Yields, Low Fees

EXC, ETR, CNP, PFE, ZBH, and SGEN Company Descriptions

CenterPoint Energy NYSE:CNP

$37.36 +0.43 (+1.16%)

Closing price 03:59 PM Eastern

Extended Trading

$37.20 -0.16 (-0.43%)

As of 08:00 PM Eastern

CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The company operates through two segments, Electric and Natural Gas. The Electric segment includes electric transmission and distribution services to electric customers and electric generation assets, as well as optimizes assets in the wholesale power market. The Natural Gas segment engages in the intrastate natural gas sales, and natural gas transportation and distribution for residential, commercial, industrial and institutional customers in Indiana, Louisiana, Minnesota, Mississippi, Ohio, and Texas; permanent pipeline connections through interconnects with various interstate and intrastate pipeline companies; and provides maintenance and repair services of home appliances to customers in Minnesota and home repair protection plans to natural gas customers in Indiana, Mississippi, Ohio, and Texas through a third party. It serves approximately 2,534,730 metered customers; owned 348 substations with transformer capacity of 79,719 megavolt amperes; and owned and operated 217 miles of intrastate pipeline in Louisiana and Texas. The company was founded in 1866 and is headquartered in Houston, Texas.

Entergy NYSE:ETR

$84.89 -1.72 (-1.99%)

Closing price 03:59 PM Eastern

Extended Trading

$86.02 +1.14 (+1.34%)

As of 07:48 PM Eastern

Entergy Corporation, together with its subsidiaries, engages in the production and retail distribution of electricity in the United States. It generates, transmits, distributes, and sells electric power in portions of Arkansas, Louisiana, Mississippi, and Texas, including the City of New Orleans; and distributes natural gas. It also engages in the ownership of interests in non-nuclear power plants that sell electric power to wholesale customers, as well as provides decommissioning services to other nuclear power plant owners. It generates electricity through gas, nuclear, coal, hydro, and solar power sources. The company sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. The company's power plants have approximately 24,000 megawatts of electric generating capacity. It delivers electricity to 3 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. Entergy Corporation was founded in 1913 and is headquartered in New Orleans, Louisiana.

Exelon NASDAQ:EXC

$47.23 +1.26 (+2.74%)

Closing price 04:00 PM Eastern

Extended Trading

$46.53 -0.70 (-1.48%)

As of 07:53 PM Eastern

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers. It also offers support services, including legal, human resources, information technology, supply management, financial, engineering, customer operations, transmission and distribution planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Pfizer NYSE:PFE

$24.30 -0.41 (-1.64%)

Closing price 03:59 PM Eastern

Extended Trading

$24.30 +0.00 (+0.00%)

As of 08:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.

Zimmer Biomet NYSE:ZBH

$112.72 +0.22 (+0.19%)

Closing price 03:59 PM Eastern

Extended Trading

$112.63 -0.09 (-0.08%)

As of 07:52 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Earnings

Compare Dividends

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EXC, ETR, CNP, PFE, ZBH, and SGEN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

EXC, ETR, CNP, PFE, ZBH, and SGEN Company Descriptions

CenterPoint Energy NYSE:CNP

Entergy NYSE:ETR

Exelon NASDAQ:EXC

Pfizer NYSE:PFE

Seagen NASDAQ:SGEN

Zimmer Biomet NYSE:ZBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools